Valneva SE (VALN)
8.69
-0.19
(-2.14%)
USD |
NASDAQ |
May 20, 10:37
Valneva Price: 8.69 for May 20, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 8.94 | 9.00 | 8.696 | 8.88 | 12039.00 |
| May 16, 2024 | 8.90 | 9.00 | 8.75 | 8.815 | 6157.00 |
| May 15, 2024 | 8.85 | 8.88 | 8.10 | 8.85 | 46060.00 |
| May 14, 2024 | 8.007 | 8.381 | 7.88 | 8.01 | 20978.00 |
| May 13, 2024 | 7.45 | 7.76 | 7.399 | 7.61 | 2855.00 |
| May 10, 2024 | 7.19 | 7.420 | 7.149 | 7.420 | 3863.00 |
| May 09, 2024 | 7.08 | 7.218 | 7.035 | 7.12 | 2158.00 |
| May 08, 2024 | 7.26 | 7.37 | 7.08 | 7.24 | 19120.00 |
| May 07, 2024 | 7.31 | 7.50 | 7.24 | 7.50 | 20047.00 |
| May 06, 2024 | 7.54 | 7.56 | 7.41 | 7.50 | 5648.00 |
| May 03, 2024 | 7.50 | 7.71 | 7.48 | 7.71 | 1423.00 |
| May 02, 2024 | 7.37 | 7.55 | 7.30 | 7.426 | 44663.00 |
| May 01, 2024 | 7.77 | 7.77 | 7.48 | 7.57 | 21394.00 |
| Apr 30, 2024 | 7.52 | 8.05 | 7.24 | 7.45 | 41663.00 |
| Apr 29, 2024 | 7.46 | 7.76 | 7.362 | 7.69 | 53023.00 |
| Apr 26, 2024 | 7.47 | 7.795 | 7.47 | 7.640 | 38113.00 |
| Apr 25, 2024 | 7.52 | 8.00 | 7.28 | 7.55 | 52747.00 |
| Apr 24, 2024 | 7.81 | 7.81 | 7.550 | 7.75 | 1633.00 |
| Apr 23, 2024 | 7.743 | 7.743 | 7.743 | 7.743 | 804.00 |
| Apr 22, 2024 | 7.76 | 7.92 | 7.76 | 7.92 | 2892.00 |
| Apr 19, 2024 | 7.82 | 7.97 | 7.583 | 7.583 | 8501.00 |
| Apr 18, 2024 | 7.76 | 8.22 | 7.76 | 8.130 | 2760.00 |
| Apr 17, 2024 | 7.794 | 7.794 | 7.500 | 7.75 | 1608.00 |
| Apr 16, 2024 | 8.15 | 8.15 | 8.000 | 8.000 | 19897.00 |
| Apr 15, 2024 | 8.68 | 8.77 | 8.45 | 8.50 | 3199.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.64
Minimum
Mar 06 2024
67.28
Maximum
Nov 29 2021
20.76
Average
14.54
Median
Nov 15 2022
Price Benchmarks
| DBV Technologies SA | 0.6527 |
| Cellectis SA | 2.94 |
| PHAXIAM Therapeutics SA (DELISTED) | 3.10 |
| Genfit SA | 4.04 |
| Innate Pharma SA | 2.92 |
Price Related Metrics
| PS Ratio | 3.656 |
| Price to Book Value | 2.959 |
| Earnings Yield | -4.73% |
| Market Cap | 604.62M |